ADC, BF, LLG, EDD, JEC, SRB, TM-MT and FKK revised the review for important intellectual content
This is why patients using oral Mounjaro alternatives often report: Weak appetite suppression No change in cravings Lack of fat-loss momentum Zero metabolic difference Side effects without results A sense of this isnt doing anything In other words, most oral tirzepatide pill forms are not effective
Your main options are: NovoCare ($199-349/month for injectable, $149-299/month for the new oral pill), or checking if alternative GLP-1s (Zepbound, Saxenda) have different coverage on your plan
It notes that real-world case reports of switching document additional weight loss, but always after complete washout and re-titration phases
The formulation warning Oral semaglutide (Rybelsus) should not be used during breastfeeding